Proinflammatory Cytokines Correlate with Depression and Anxiety in Colorectal Cancer Patients

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Oliveira Miranda, Diego ^a   Soares De Lima, Taís Aparecida ^a   Ribeiro Azevedo, Lucas ^b   Feres, Omar ^a   Ribeiro Da Rocha, José Joaquim ^a   Pereira Da Silva, Gabriela ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DEPRESSION; DISEASE SEVERITY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; BLOOD; COLORECTAL TUMOR; COMPLICATION; DEMOGRAPHY; METABOLISM; PSYCHOLOGY;

ADULT; ANXIETY; COLORECTAL NEOPLASMS; CYTOKINES; DEMOGRAPHY; DEPRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED;

EID: 84935911794     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/739650     Document Type: Article

References (24)

1. J. Ferlay, I. Soerjomataram, M. Ervik et al., GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide in 2012 : IARC Cancer Base No. 11, International Agency for Research on Cancer, Lyon, France, 2013, http://globocan.iarc.fr.
2. Ministry of Health of Brazil, and National Cancer Institute, "Estimates/2014-ncidence of cancer in Brazil, " INCA, Rio de Janeiro, Brazil, 2013, http://www.inca.gov.br.
3. J. Dunn, B. Lynch, M. Rinaldis et al., "Dimensions of quality of life and psychosocial variables most salient to colorectal cancer patients, " Psycho-Oncology, vol. 15, no. 1, pp. 20-30, 2006.
4. A. Tsunoda, K. Nakao, K. Hiratsuka, N. Yasuda, M. Shibusawa, and M. Kusano, "Anxiety, depression and quality of life in colorectal cancer patients, " International Journal of Clinical Oncology, vol. 10, no. 6, pp. 411-417, 2005.
5. M. Medeiros, C. T. F. Oshima, and N. M. Forones, "Depression and anxiety in colorectal cancer patients, " Journal of Gastrointestinal Cancer, vol. 41, no. 3, pp. 179-184, 2010.
6. S. M. B. Bottino, R. Fraguas, andW. F. Gattaz, "Depression and cancer, " Revista de Psiquiatria Clinica, vol. 36, no. 3, pp. 109-115, 2009.
7. C. L. Carmack, K. Basen-Engquist, Y. Yuan et al., "Feasibility of an expressive-disclosure group intervention for post-treatment colorectal cancer patients: results of the Healthy Expressions study, " Cancer, vol. 117, no. 21, pp. 4993-5002, 2011.
8. A. Alacacioglu, O. Binicier., O. Gungor, I. Oztop, M. Dirioz, and U. Yilmaz, "Quality of life, anxiety, and depression in Turkish colorectal cancer patients, " Supportive Care in Cancer, vol. 18, no. 4, pp. 417-421, 2010.
9. A. Szkaradkiewicz, R. Marciniak, I. Chudzicka-Strugala et al., "Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients, " Archivum Immunologiae et Therapiae Experimentalis, vol. 57, no. 4, pp. 291-294, 2009.
10. S. I. Grivennikov and M. Karin, "Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage, " Annals of the Rheumatic Diseases, vol. 70, no. 1, pp. i104-i108, 2011.
11. N. J. Botega, M. R. Bio, M. A. Zomignani, C. Garcia Jr., andW. A. Pereira, "Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD, " Revista de saude publica, vol. 29, no. 5, pp. 355-363, 1995.
12. A. S. Zigmond and R. P. Snaith, "The hospital anxiety and depression scale, " Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361-370, 1983.
13. D. Razavi, N. Delvaux, C. Farvacques, and E. Robaye, "Screening for adjustment disorders and major depressive disorders in cancer in-patients, " British Journal of Psychiatry, vol. 156, pp. 79-83, 1990.
14. U. Wedding, A. Koch, B. Rohrig et al., "Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy, " Acta Oncologica, vol. 47, no. 1, pp. 56-62, 2008.
15. N. M. Gray, S. J. Hall, and S. Browne, "Predictors of anxiety and depression in people with colorectal cancer, " Supportive Care in Cancer, vol. 22, no. 2, pp. 307-314, 2013.
16. L. M. Pyter, V. Pineros, J. A. Galang, M. K. McClintock, and B. J. Prendergast, "Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamicpituitary-adrenal axis regulation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 22, pp. 9069-9074, 2009.
17. T. G. Allen-Marsh, C. Glover, C. Fordy, D. C. Henderson, andM. Davies, "Relation between depression and circulating immune products in patients with advanced colorectal cancer, " Journal of the Royal Society ofMedicine, vol. 91, no. 8, pp. 408-413, 1998.
18. D. L. Musselman, A. H. Miller, M. R. Porter et al., "Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings, " The American Journal of Psychiatry, vol. 158, no. 8, pp. 1252-1257, 2001.
19. J. C. Felger and F. E. Lotrich, "Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications, " Neuroscience, vol. 246, pp. 199-229, 2013.
20. J. Illman, R. Corringham, D. Robinson Jr. et al., "Are inflammatory cytokines the common link between cancer-associated cachexia and depression?" Journal of Supportive Oncology, vol. 3, no. 1, pp. 37-50, 2005.
21. T. Rich, P. F. Innominato, J. Boerner et al., "Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer, " Clinical Cancer Research, vol. 11, no. 5, pp. 1757-1764, 2005.
22. B. Seruga, H. Zhang, L. J. Bernstein, and I. F. Tannock, "Cytokines and their relationship to the symptoms and outcome of cancer, " Nature Reviews Cancer, vol. 8, no. 11, pp. 887-899, 2008.
23. E. Spath-Schwalbe, K. Hansen, F. Schmidt et al., "Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men, " Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 5, pp. 1573-1579, 1998.
24. S. C. Segerstrom, "Individual differences, immunity, and cancer: lessons from personality psychology, " Brain, Behavior, and Immunity, vol. 17, no. 1, pp. S92-S97, 2003.